Comparison of different doses of cisatracurium for intubatio
Phase 3
- Conditions
- Health Condition 1: - Health Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2024/03/064130
- Lead Sponsor
- iroo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with American Society of
Anaesthesiology class 1 or class 2
2. Age 18 to 60 years of either sex.
3. Mallampatti class 1 or class 2
Exclusion Criteria
1. Patient with allergy to study drug
2. Patients with anticipated difficult intubation
3. Pregnant and lactating patients
4. Patients receiving drugs known to interact
with neuromuscular blocking agents
5. Patients with neuromuscular disorder
6. Asthmatic and psychiatric patients on
medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset of action of study drug <br/ ><br> <br/ ><br> Intubating scoreTimepoint: After administration of study drug untill TOF score becomes zero at baseline.
- Secondary Outcome Measures
Name Time Method 1. Duration of action of the <br/ ><br> study drug <br/ ><br>2. Haemodynamic and peripheral <br/ ><br> oxygen saturation <br/ ><br>3. Side effectTimepoint: Outcome will be continuously recorded just after administration of drug,3 minutes,5minutes then every 5 minutes untill the sign of spontaneous breathing.